GeneDx Holdings (WGS) Tops Q2 EPS by 38c ; Offers Guidance

GeneDx Holdings (NASDAQ: WGS) reported Q2 EPS of $0.50, $0.38 better than the analyst estimate of $0.12. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $85.45 million.

GUIDANCE:

GeneDx Holdings sees FY2025 revenue of $400-415 million, versus the consensus of $369.5 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
• Aehr Test Systems receives $22M follow-on order for AI burn-in systems
• Four key things investors will watch in Nvidia's earnings next week